Literature DB >> 6279587

Counteraction of calcium-activated, phospholipid-dependent protein kinase activation by adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in platelets.

Y Takai, K Kaibuchi, K Sano, Y Nishizuka.   

Abstract

In intact human platelets activated by thrombin, diacylglycerol is produced with the concomitant disappearance of phosphatidylinositol (PI). This reaction is associated with phosphorylation of a protein having a molecular weight of about 40,000 (40 K protein) and serotonin release. All the reactions are inhibited in a parallel manner by incubation of platelets with either dibutyryl cyclic AMP or 8-bromocyclic GMP, prior to the stimulation by thrombin. The inhibition of these reactions is inversely related to phosphorylation of another group of platelet proteins. Since Ca2+-activated, phospholipid-dependent protein kinase (C-Kinase) is activated by diacylglycerol and is responsible for 40 K protein phosphorylation (Kawahara, Y., Takai, Y., Minakuchi, R., Sano, K., & Nishizuka, Y. (1980) Biochem. Biophys. Res. Commun. 97, 309-317), the results suggest that in platelets both cyclic AMP and cyclic GMP may serve as inhibitors of C-Kinase by counteracting the receptor-linked PI breakdown probably through the actions of cyclic nucleotide-dependent protein kinases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279587     DOI: 10.1093/oxfordjournals.jbchem.a133700

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  16 in total

1.  Phorbol myristate acetate, dioctanoylglycerol, and phosphatidic acid inhibit the hydroosmotic effect of vasopressin on rabbit cortical collecting tubule.

Authors:  Y Ando; H R Jacobson; M D Breyer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

2.  Modulation of fluoroaluminate-induced inositol phosphate formation by increases in tissue cyclic AMP content in bovine tracheal smooth muscle.

Authors:  I P Hall; J Donaldson; S J Hill
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

3.  Converging adrenergic and cholinergic mechanisms in the inhibition of Cl secretion in fish opercular epithelium.

Authors:  S A May; K J Degnan
Journal:  J Comp Physiol B       Date:  1985       Impact factor: 2.200

4.  Cyclic adenosine monophosphate and diacylglycerol. Mutually inhibitory second messengers in cultured rat inner medullary collecting duct cells.

Authors:  I Teitelbaum
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.

Authors:  J C Fantone; W A Marasco; L J Elgas; P A Ward
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

6.  Purified rat brain calcium- and phospholipid-dependent protein kinase phosphorylates ribosomal protein S6.

Authors:  C J Le Peuch; R Ballester; O M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+.

Authors:  P De Togni; G Cabrini; F Di Virgilio
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

8.  Inositol phosphate metabolism in bradykinin-stimulated human A431 carcinoma cells. Relationship to calcium signalling.

Authors:  B C Tilly; P A van Paridon; I Verlaan; K W Wirtz; S W de Laat; W H Moolenaar
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

9.  Prostacyclin inhibits platelet aggregation induced by phorbol ester or Ca2+ ionophore at steps distal to activation of protein kinase C and Ca2+-dependent protein kinases.

Authors:  W Siess; E G Lapetina
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

10.  Interactions between intracellular cyclic AMP and agonist-induced inositol phospholipid breakdown in isolated gastric mucosal cells of the rat.

Authors:  J Puurunen; M J Lohse; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.